OTHER OPPORTUNISTIC MOLD INFECTIONS
Fungi previously considered to be harmless colonizers, including Pseudallescheria boydii (Scedosporium apiospermum), Scedosporium prolificans, Fusarium, Paecilomyces, Trichoderma longibrachiatium, and Trichosporon, are now significant pathogens in immunocompromised patients. Opportunistic infections with these agents are seen in patients being treated for hematologic malignancies, stem cell or organ transplant recipients, and in those receiving broad-spectrum antifungal prophylaxis. Infection may be localized in the skin, lungs, or sinuses, or widespread disease may appear with lesions in multiple organs. Fusariosis should be suspected in severely immunosuppressed persons in whom multiple, painful skin lesions develop; blood cultures are often positive. Sinus infection may cause bony erosion. Infection in subcutaneous tissues following traumatic implantation may develop as a well-circumscribed cyst or as an ulcer.
Nonpigmented septate hyphae are seen in tissue and are indistinguishable from those of Aspergillus when infections are due to S apiospermum or species of Fusarium, Paecilomyces, Penicillium, or other hyaline molds. Spores or mycetoma-like granules are rarely present in tissue. The differentiation of S apiospermum and Aspergillus is particularly important, since the former is uniformly resistant to amphotericin B but may be sensitive to azole antifungals (eg, voriconazole). Treatment of fusariosis may include amphotericin, voriconazole, or combination therapy; there are limited data on the use of isavuconazole or posaconazole for this disease. In addition to antifungal therapy, reversal of underlying immunosuppression is an essential component of treatment for these invasive mold infections.
Infection by any of a number of black molds is designated as phaeohyphomycosis. These black molds (eg, Exophiala, Bipolaris, Cladophialophora, Curvularia, Alternaria) are common in the environment, especially on decaying vegetation. In tissues of patients with phaeohyphomycosis, the mold is seen as black or faintly brown hyphae, yeast cells, or both. Culture on appropriate medium is needed to identify the agent. Histologic demonstration of these organisms is definitive evidence of invasive infection; positive cultures must be interpreted cautiously and not assumed to be contaminants in immunocompromised hosts.
et al. Therapeutic challenges of non-Aspergillus
invasive mold infections in immunosuppressed patients. Antimicrob Agents Chemother. 2019 Oct 22;63(11):e01244–19.
et al. Characteristics and risk factors for mortality of invasive non-Aspergillus
mould infections in patients with haematologic diseases: a single-centre 7-year cohort study. Mycoses. 2020 Mar;63(3):257–64.
et al. Comparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosis. Diagn Microbiol Infect Dis. 2019 Nov;95(3):114861.
et al. Recent advances in the treatment of scedosporiosis and fusariosis. J Fungi (Basel). 2018 Jun 18;4(2):E73.